Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays.
Standard
Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays. / Galel, Susan A; Strong, D Michael; Tegtmeier, Gary E; Holland, Paul V; Kuramoto, Isamu K; Kemper, Markus J.; Pietrelli, Larry; Gallarda, James.
In: TRANSFUSION, Vol. 42, No. 11, 11, 2002, p. 1507-1513.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays.
AU - Galel, Susan A
AU - Strong, D Michael
AU - Tegtmeier, Gary E
AU - Holland, Paul V
AU - Kuramoto, Isamu K
AU - Kemper, Markus J.
AU - Pietrelli, Larry
AU - Gallarda, James
PY - 2002
Y1 - 2002
N2 - Two HCV antibody tests (EIA 2.0 [EIA2], Abbott; and the Version 3.0 ELISA [EIA3], Ortho) are currently licensed for screening of US blood donors. Testing of donors for HCV RNA allows comparison of the sensitivities of the two antibody-screening assays.
AB - Two HCV antibody tests (EIA 2.0 [EIA2], Abbott; and the Version 3.0 ELISA [EIA3], Ortho) are currently licensed for screening of US blood donors. Testing of donors for HCV RNA allows comparison of the sensitivities of the two antibody-screening assays.
KW - Adult
KW - Humans
KW - Male
KW - Female
KW - Reproducibility of Results
KW - Sensitivity and Specificity
KW - Predictive Value of Tests
KW - Follow-Up Studies
KW - Time Factors
KW - Genotype
KW - Immunoblotting
KW - Biological Markers
KW - United States/epidemiology
KW - Mass Screening/methods
KW - Alanine Transaminase/blood
KW - Blood Donors
KW - Enzyme-Linked Immunosorbent Assay
KW - Hepacivirus/genetics/immunology/isolation & purification
KW - Hepatitis C/blood/diagnosis/epidemiology/virology
KW - Hepatitis C Antibodies/blood
KW - Immunoenzyme Techniques
KW - RNA, Viral/blood
KW - Seroepidemiologic Studies
KW - Viremia/blood/diagnosis/epidemiology/virology
KW - Adult
KW - Humans
KW - Male
KW - Female
KW - Reproducibility of Results
KW - Sensitivity and Specificity
KW - Predictive Value of Tests
KW - Follow-Up Studies
KW - Time Factors
KW - Genotype
KW - Immunoblotting
KW - Biological Markers
KW - United States/epidemiology
KW - Mass Screening/methods
KW - Alanine Transaminase/blood
KW - Blood Donors
KW - Enzyme-Linked Immunosorbent Assay
KW - Hepacivirus/genetics/immunology/isolation & purification
KW - Hepatitis C/blood/diagnosis/epidemiology/virology
KW - Hepatitis C Antibodies/blood
KW - Immunoenzyme Techniques
KW - RNA, Viral/blood
KW - Seroepidemiologic Studies
KW - Viremia/blood/diagnosis/epidemiology/virology
M3 - SCORING: Journal article
VL - 42
SP - 1507
EP - 1513
JO - TRANSFUSION
JF - TRANSFUSION
SN - 0041-1132
IS - 11
M1 - 11
ER -